Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 242

1.

Fatal outcome after reactivation of inherited chromosomally integrated HHV-6A (iciHHV-6A) transmitted through liver transplantation.

Bonnafous P, Marlet J, Bouvet D, Salamé E, Tellier AC, Guyetant S, Goudeau A, Agut H, Gautheret-Dejean A, Gaudy-Graffin C.

Am J Transplant. 2018 Jun;18(6):1548-1551. doi: 10.1111/ajt.14657. Epub 2018 Jan 27.

2.

Recurrent herpetic keratitis despite antiviral prophylaxis: A virological and pharmacological study.

Rousseau A, Boutolleau D, Titier K, Bourcier T, Chiquet C, Weber M, Colin J, Gueudry J, M'Garrech M, Bodaghi B, Burrel S, Agut H, Deback C; HEDGOF (Herpes Eye Disease Group of France), Labetoulle M.

Antiviral Res. 2017 Oct;146:205-212. doi: 10.1016/j.antiviral.2017.09.013. Epub 2017 Sep 20.

PMID:
28939476
3.

Human Herpesvirus 6 (HHV-6) necrotizing encephalitis, a rare condition in immunocompromised patients: The importance of brain biopsy associated with HHV-6 testing.

Le Guennec L, Mokhtari K, Chauvet D, Dupuis N, Roos-Weil D, Agut H, Leclercq D, Psimaras D, Mayaux J, Demeret S, Choquet S, Auvin S, Bonnafous P, Gautheret-Dejean A, Weiss N.

J Neurol Sci. 2017 Jun 15;377:112-115. doi: 10.1016/j.jns.2017.04.003. Epub 2017 Apr 6. No abstract available.

PMID:
28477677
4.

Ancient Recombination Events between Human Herpes Simplex Viruses.

Burrel S, Boutolleau D, Ryu D, Agut H, Merkel K, Leendertz FH, Calvignac-Spencer S.

Mol Biol Evol. 2017 Jul 1;34(7):1713-1721. doi: 10.1093/molbev/msx113.

5.

Cytokine and cellular responses to human herpesvirus-6B in patients with B-acute lymphoblastic leukemia.

Nefzi F, Lambert C, Gautheret-Dejean A, Fisson S, Khebizi Q, Khelif A, Agut H, Aouni M.

Microbiol Immunol. 2016 Nov;60(11):770-777. doi: 10.1111/1348-0421.12452.

6.

Où en est la recherche sur les antiviraux ?

Agut H, Burrel S, Bonnafous P, Boutolleau D.

Rev Prat. 2016 Nov;66(9):1007-1014. French.

PMID:
30512372
7.

Update on infections with human herpesviruses 6A, 6B, and 7.

Agut H, Bonnafous P, Gautheret-Dejean A.

Med Mal Infect. 2017 Mar;47(2):83-91. doi: 10.1016/j.medmal.2016.09.004. Epub 2016 Oct 20. Review.

PMID:
27773488
8.

Human Herpesviruses 6A, 6B, and 7.

Agut H, Bonnafous P, Gautheret-Dejean A.

Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.DMIH2-0007-2015. Review.

PMID:
27337451
9.

[Diagnosis and practice of virological monitoring of infections by the human herpesviruses 6A and 6B].

Gautheret-Dejean A, Bonnafous P, Agut H.

Ann Biol Clin (Paris). 2016 Mar-Apr;74(2):156-67. doi: 10.1684/abc.2016.1122. Review. French.

10.

Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals.

Perrier M, Désiré N, Deback C, Agut H, Boutolleau D, Burrel S.

J Virol Methods. 2016 Jul;233:10-4. doi: 10.1016/j.jviromet.2016.03.006. Epub 2016 Mar 16.

PMID:
26994966
11.

High conservation of herpes simplex virus UL5/UL52 helicase-primase complex in the era of new antiviral therapies.

Collot M, Rouard C, Brunet C, Agut H, Boutolleau D, Burrel S.

Antiviral Res. 2016 Apr;128:1-6. doi: 10.1016/j.antiviral.2016.01.015. Epub 2016 Jan 28.

PMID:
26826441
12.

[Viral infections of human central nervous system].

Agut H.

Ann Biol Clin (Paris). 2016 Jan-Feb;74(1):55-67. doi: 10.1684/abc.2015.1109. Review. French.

13.

Tenofovir Gel to Prevent HSV-2 Infection.

Agut H, Burrel S, Boutolleau D.

N Engl J Med. 2015 Nov 12;373(20):1980. doi: 10.1056/NEJMc1511338. No abstract available.

PMID:
26559586
14.

Genetic Diversity within Alphaherpesviruses: Characterization of a Novel Variant of Herpes Simplex Virus 2.

Burrel S, Désiré N, Marlet J, Dacheux L, Seang S, Caumes E, Bourhy H, Agut H, Boutolleau D.

J Virol. 2015 Dec;89(24):12273-83. doi: 10.1128/JVI.01959-15. Epub 2015 Sep 23.

15.

Laboratory and clinical aspects of human herpesvirus 6 infections.

Agut H, Bonnafous P, Gautheret-Dejean A.

Clin Microbiol Rev. 2015 Apr;28(2):313-35. doi: 10.1128/CMR.00122-14. Review.

16.

Le virus Ébola et sa detection.

Agut H.

Bull Acad Natl Med. 2014 Nov;198(8):1493-500. French.

PMID:
27125034
17.

Management of multidrug-resistant CMV infection in immunocompromised patients: case report of a heart-transplant recipient and review of the literature.

Deback C, Burrel S, Varnous S, Carcelain G, Conan F, Aït-Arkoub Z, Autran B, Gandjbakhch I, Agut H, Boutolleau D.

Antivir Ther. 2015;20(2):249-54. doi: 10.3851/IMP2818. Epub 2014 Jun 25. Review.

PMID:
25219330
18.

Human cytomegalovirus (CMV) susceptibility to currently approved antiviral drugs does not impact on CMV terminase complex polymorphism.

Pilorgé L, Burrel S, Aït-Arkoub Z, Agut H, Boutolleau D.

Antiviral Res. 2014 Nov;111:8-12. doi: 10.1016/j.antiviral.2014.08.014. Epub 2014 Sep 4.

PMID:
25194992
19.

Impact of HIV-1 infection on herpes simplex virus type 2 genetic variability among co-infected individuals.

Abrão EP, Burrel S, Désiré N, Bonnafous P, Godet A, Caumes E, Agut H, Boutolleau D.

J Med Virol. 2015 Mar;87(3):357-65. doi: 10.1002/jmv.24061. Epub 2014 Sep 1.

PMID:
25174847
20.

Presence of HHV-6 genome in spermatozoa in a context of couples with low fertility: what type of infection?

Godet AN, Soignon G, Koubi H, Bonnafous P, Agut H, Poirot C, Gautheret-Dejean A.

Andrologia. 2015 Jun;47(5):531-5. doi: 10.1111/and.12299. Epub 2014 May 20.

PMID:
24846813
21.

Low titers of serum antibodies inhibiting hemagglutination predict fatal fulminant influenza A(H1N1) 2009 infection.

Guihot A, Luyt CE, Parrot A, Rousset D, Cavaillon JM, Boutolleau D, Fitting C, Pajanirassa P, Mallet A, Fartoukh M, Agut H, Musset L, Zoorob R, Kirilovksy A, Combadière B, van der Werf S, Autran B, Carcelain G; FluBAL Study Group.

Am J Respir Crit Care Med. 2014 May 15;189(10):1240-9. doi: 10.1164/rccm.201311-2071OC.

PMID:
24646009
22.

Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.

Seang S, Boutolleau D, Burrel S, Regnier S, Epelboin L, Voujon D, Valantin MA, Katlama C, Agut H, Caumes E.

Int J STD AIDS. 2014 Aug;25(9):676-82. doi: 10.1177/0956462413518034. Epub 2014 Feb 17.

PMID:
24535691
23.

Classification of HHV-6A and HHV-6B as distinct viruses.

Ablashi D, Agut H, Alvarez-Lafuente R, Clark DA, Dewhurst S, DiLuca D, Flamand L, Frenkel N, Gallo R, Gompels UA, Höllsberg P, Jacobson S, Luppi M, Lusso P, Malnati M, Medveczky P, Mori Y, Pellett PE, Pritchett JC, Yamanishi K, Yoshikawa T.

Arch Virol. 2014 May;159(5):863-70. doi: 10.1007/s00705-013-1902-5. Epub 2013 Nov 6. Review.

24.

Validation of the QIAsymphony RGQ system for DNA quantitation of different BK virus genotypes in whole blood samples.

Burrel S, Brunet C, Hamm N, Gits-Muselli M, Hermet L, Aimé C, Agut H, Boutolleau D.

J Virol Methods. 2014 Feb;196:32-5. doi: 10.1016/j.jviromet.2013.10.030. Epub 2013 Oct 30.

PMID:
24184087
25.

Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey.

Burrel S, Aime C, Hermet L, Ait-Arkoub Z, Agut H, Boutolleau D.

Antiviral Res. 2013 Nov;100(2):365-72. doi: 10.1016/j.antiviral.2013.09.012. Epub 2013 Sep 25.

PMID:
24075863
26.

Molecular characterization of herpes simplex virus 2 strains by analysis of microsatellite polymorphism.

Burrel S, Ait-Arkoub Z, Voujon D, Deback C, Abrao EP, Agut H, Boutolleau D.

J Clin Microbiol. 2013 Nov;51(11):3616-23. doi: 10.1128/JCM.01714-13. Epub 2013 Aug 21.

27.

Polymorphism of gp41 glycoprotein might influence the progression to disease in HIV-1 infection.

Potard V, Ait-Arkoub Z, Agut H; ALT ANRS CO15 Study Group.

AIDS. 2013 Apr 24;27(7):1189-91. doi: 10.1097/QAD.0b013e32835f6b30.

PMID:
23902923
28.

Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.

Burrel S, Boutolleau D, Azar G, Doan S, Deback C, Cochereau I, Agut H, Gabison EE.

J Clin Virol. 2013 Sep;58(1):321-4. doi: 10.1016/j.jcv.2013.05.001. Epub 2013 May 31.

PMID:
23731845
29.

Detection of a new variant of herpes simplex virus type 2 among HIV-1-infected individuals.

Burrel S, Abrao EP, Désiré N, Seang S, Caumes E, Agut H, Boutolleau D.

J Clin Virol. 2013 Jul;57(3):267-9. doi: 10.1016/j.jcv.2013.03.008. Epub 2013 Apr 5. No abstract available.

PMID:
23567026
30.

A molecular basis for the control of preimmune escape variants by HIV-specific CD8+ T cells.

Ladell K, Hashimoto M, Iglesias MC, Wilmann PG, McLaren JE, Gras S, Chikata T, Kuse N, Fastenackels S, Gostick E, Bridgeman JS, Venturi V, Arkoub ZA, Agut H, van Bockel DJ, Almeida JR, Douek DC, Meyer L, Venet A, Takiguchi M, Rossjohn J, Price DA, Appay V.

Immunity. 2013 Mar 21;38(3):425-36. doi: 10.1016/j.immuni.2012.11.021.

31.

The response of medical virology laboratories to the influenza A(H1N1)pdm09 outbreak in Paris Île-de-France region.

Seringe E, Agut H.

Pathol Biol (Paris). 2013 Oct;61(5):203-8. doi: 10.1016/j.patbio.2012.11.002. Epub 2012 Dec 27.

PMID:
23273748
32.

HDP-CDV as an alternative for treatment of human herpesvirus-6 infections.

Bonnafous P, Bogaert S, Godet AN, Agut H.

J Clin Virol. 2013 Feb;56(2):175-6. doi: 10.1016/j.jcv.2012.11.006. Epub 2012 Nov 21. No abstract available.

PMID:
23177166
33.

Impact of novel mutations of herpes simplex virus 1 and 2 thymidine kinases on acyclovir phosphorylation activity.

Burrel S, Bonnafous P, Hubacek P, Agut H, Boutolleau D.

Antiviral Res. 2012 Dec;96(3):386-90. doi: 10.1016/j.antiviral.2012.09.016. Epub 2012 Oct 3.

PMID:
23041200
34.

Human immunodeficiency virus type-1 (HIV-1) continues to evolve in presence of broadly neutralizing antibodies more than ten years after infection.

Chaillon A, Braibant M, Hué S, Bencharif S, Enard D, Moreau A, Samri A, Agut H, Barin F.

PLoS One. 2012;7(8):e44163. doi: 10.1371/journal.pone.0044163. Epub 2012 Aug 30.

35.

Routine use of duplex real-time PCR assays including a commercial internal control for molecular diagnosis of opportunistic DNA virus infections.

Burrel S, Fovet C, Brunet C, Ovaguimian L, Hamm N, Conan F, Kalkias L, Agut H, Boutolleau D.

J Virol Methods. 2012 Oct;185(1):136-41. doi: 10.1016/j.jviromet.2012.05.031. Epub 2012 Jul 2.

PMID:
22766177
36.

Emergence of cytomegalovirus resistance to foscarnet in a patient receiving foscarnet salvage therapy for multidrug-resistant HIV infection.

Boutolleau D, Canestri A, Burrel S, Wirden M, Seang S, Clavel-Osorio C, Marcelin AG, Katlama C, Agut H.

J Clin Virol. 2012 Jun;54(2):194-6. doi: 10.1016/j.jcv.2012.02.008. Epub 2012 Mar 6.

PMID:
22398036
37.

Confirmation of the low clinical effect of human herpesvirus-6 and -7 infections after renal transplantation.

Caïola D, Karras A, Flandre P, Boutolleau D, Scieux C, Agut H, Legendre C, Gautheret-Dejean A.

J Med Virol. 2012 Mar;84(3):450-6. doi: 10.1002/jmv.23206.

PMID:
22246831
38.

Clinical and microbiological evaluation of travel-associated respiratory tract infections in travelers returning from countries affected by pandemic A(H1N1) 2009 influenza.

Jauréguiberry S, Boutolleau D, Grandsire E, Kofman T, Deback C, Aït-Arkoub Z, Bricaire F, Agut H, Caumes E.

J Travel Med. 2012 Jan-Feb;19(1):22-7. doi: 10.1111/j.1708-8305.2011.00570.x. Epub 2011 Dec 8.

39.

Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.

Lascaux AS, Caumes E, Deback C, Melica G, Challine D, Agut H, Lévy Y.

J Med Virol. 2012 Feb;84(2):194-7. doi: 10.1002/jmv.23188.

PMID:
22170537
40.

Quantitation of human herpesvirus-6A, -6B and -7 DNAs in whole blood, mononuclear and polymorphonuclear cell fractions from healthy blood donors.

Géraudie B, Charrier M, Bonnafous P, Heurté D, Desmonet M, Bartoletti MA, Penasse C, Agut H, Gautheret-Dejean A.

J Clin Virol. 2012 Feb;53(2):151-5. doi: 10.1016/j.jcv.2011.10.017. Epub 2011 Nov 30.

PMID:
22133730
41.

Genotypic characterization of herpes simplex virus DNA polymerase UL42 processivity factor.

Burrel S, Aït-Arkoub Z, Agut H, Boutolleau D.

Antiviral Res. 2012 Jan;93(1):199-203. doi: 10.1016/j.antiviral.2011.10.016. Epub 2011 Oct 28.

PMID:
22061617
42.

Chromosomally integrated human herpesvirus 6: questions and answers.

Pellett PE, Ablashi DV, Ambros PF, Agut H, Caserta MT, Descamps V, Flamand L, Gautheret-Dejean A, Hall CB, Kamble RT, Kuehl U, Lassner D, Lautenschlager I, Loomis KS, Luppi M, Lusso P, Medveczky PG, Montoya JG, Mori Y, Ogata M, Pritchett JC, Rogez S, Seto E, Ward KN, Yoshikawa T, Razonable RR.

Rev Med Virol. 2012 May;22(3):144-55. doi: 10.1002/rmv.715. Epub 2011 Nov 4. Review.

43.

Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections.

Agut H.

J Clin Virol. 2011 Nov;52(3):164-71. doi: 10.1016/j.jcv.2011.06.008. Epub 2011 Jul 22. Review.

PMID:
21782505
44.

Genotypic characterization of human cytomegalovirus UL97 phosphotransferase natural polymorphism in the era of ganciclovir and maribavir.

Boutolleau D, Burrel S, Agut H.

Antiviral Res. 2011 Jul;91(1):32-5. doi: 10.1016/j.antiviral.2011.04.015. Epub 2011 May 4.

PMID:
21570426
45.

Herpes simplex encephalitis : from virus to therapy.

Rozenberg F, Deback C, Agut H.

Infect Disord Drug Targets. 2011 Jun;11(3):235-50. Review.

PMID:
21488834
46.

Performance of the DiaSorin LIAISON(®) anti-HBs II for the detection of hepatitis B surface antibodies: comparison with the Abbott Architect anti-HBs assay.

Kinn S, Akhavan S, Agut H, Thibault V.

J Clin Virol. 2011 Apr;50(4):297-302. doi: 10.1016/j.jcv.2011.01.009. Epub 2011 Feb 16.

PMID:
21330194
47.

The spectrum of malignancies in HIV-infected patients in 2006 in France: the ONCOVIH study.

Lanoy E, Spano JP, Bonnet F, Guiguet M, Boué F, Cadranel J, Carcelain G, Couderc LJ, Frange P, Girard PM, Oksenhendler E, Poizot-Martin I, Semaille C, Agut H, Katlama C, Costagliola D; ONCOVIH study group.

Int J Cancer. 2011 Jul 15;129(2):467-75. doi: 10.1002/ijc.25903. Epub 2011 Apr 27.

48.

[Acute human herpesvirus 6 (HHV-6) infections: when and how to treat?].

Agut H.

Pathol Biol (Paris). 2011 Apr;59(2):108-12. doi: 10.1016/j.patbio.2010.07.015. Epub 2010 Sep 15. Review. French.

PMID:
20832191
49.

Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.

Burrel S, Deback C, Agut H, Boutolleau D.

Antimicrob Agents Chemother. 2010 Nov;54(11):4833-42. doi: 10.1128/AAC.00669-10. Epub 2010 Aug 23.

50.

Disease progression due to dual infection in an HLA-B57-positive asymptomatic long-term nonprogressor infected with a nef-defective HIV-1 strain.

Braibant M, Xie J, Samri A, Agut H, Autran B, Barin F.

Virology. 2010 Sep 15;405(1):81-92. doi: 10.1016/j.virol.2010.05.026. Epub 2010 Jun 19.

Supplemental Content

Support Center